The SEC remained active over the holiday break with a number of companies filing to go public. Furthermore, one company did not waste any time setting terms for a first IPO of the year. <\/p>\n
Cullinan Oncology, LLC (GGEM)<\/strong> is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The company will be seeking a market cap of $643m-$719m by selling 8.33mm shares at a $17-$19 range. \u00a0Morgan Stanley, SVB Leerink and Evercore ISI will have the honors of being the underwriters for the first IPO and as CGEM will debut on Friday (1\/8)..<\/p>\n Update: (9:50am ET) — Another IPO launched to debut this week.\u00a0Gracell Biotechnologies Inc (GRCL)<\/strong>, \u00a0a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical needs in the treatment of cancer, is selling 8.825mm ADSs at $16-$18 which would seek a market cap of $1.0b-$1.14b. Citigroup, Jefferies, Piper Sandler and Wells Fargo are the lead underwriters on this offering.\u00a0<\/span><\/p>\n NEW FILINGS<\/strong><\/span><\/p>\n Company: AmeriHome, Inc. Company: RLX Technology, Inc. Company: ZIM Integrated Shipping Services Ltd. Company: Patria Investments Limited Company: Shoals Technology Group, Inc. Company: MYT Netherlands Parent B.V. Company: Qualtrics International Inc. Company: MYT Netherlands Parent B.V. Company: Motorsport Gaming US LLC Company: Playtika Holding Corp. Company: Kuke Music Holding Limited TERMS ADDED<\/strong><\/span><\/p>\n Company: Cullinan Oncology, LLC Company: Gracell Biotechnologies Inc. The SEC remained active over the holiday break with a number of companies filing to go public. Furthermore, one company did not waste any time setting terms for a first IPO of the year.<\/p>\n","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[],"class_list":["post-16713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/16713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=16713"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/16713\/revisions"}],"predecessor-version":[{"id":16721,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/16713\/revisions\/16721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=16713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=16713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=16713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSymbol: AHM
\nDescription: They are the No.1 branded e-vapor company in China, capturing 48.0% and 62.6% of the market share of closed-system e-vapor products in terms of retail sales value in 2019 and the nine months ended September 30, 2020, respectively, according to the CIC Report.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse Securities, Goldman Sachs, J.P. Morgan Securities, Wells Fargo, Barclays Capital, BofA Securities, Citigroup RBC Capital Markets UBS Investment Bank
\nCo-Manager(s): Apollo Global Securities, Houlihan Lokey, Siebert Williams Shank & Co
\nFiled: 1-04-21
\nListed Cash Raise: $100m
\nNote: Previously Postponed in October 2020<\/p>\n
\nSymbol: RLX
\nDescription: They are the No.1 branded e-vapor company in China, capturing 48.0% and 62.6% of the market share of closed-system e-vapor products in terms of retail sales value in 2019 and the nine months ended September 30, 2020, respectively, according to the CIC Report.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): China Renaissance
\nFiled: 12-31-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ZIM
\nDescription: They are a global, asset-light container liner shipping company with leadership positions in niche markets where we believe we have distinct competitive advantages that allow us to maximize our market position and profitability.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Goldman Sachs, Barclays, Jefferies, Clarksons Platou Securities
\nFiled: 12-30-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: PAX
\nDescription: They are one of the leading private markets investment firms in Latin America in terms of capital raised, with over US$7.8 billion raised in the past five years.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, BofA Securities, Credit Suisse
\nFiled: 12-30-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: SHLS
\nDescription: They are a leading provider of electrical balance of system or \u201cEBOS\u201d solutions for solar energy projects in the United States.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, UBS Investment Group
\nFiled: 12-30-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: MYTE
\nDescription: They are a leading luxury e-commerce platform for the global luxury fashion consumer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, Credit Suisse, UBS Investment Bank, Jefferies, Cowen
\nFiled: 12-28-20
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: XM
\nDescription: They have pioneered a new category of software, experience management, or XM, which enables organizations to succeed in today\u2019s experience economy.
\nShares: TBD
\nPrice Range: $20.00-$24.00
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, BofA Securities, Barclays, Deutsche Bank Securities, Goldman Sachs, HSBC, Citigroup, BMO Capital Markets, Truist Securities, Canaccord Genuity, Evercore ISI, JMP Securities, Oppenheimer & Co., Piper Sandler, Raymond James, William Blair
\nCo-Managers: Loop Capital Markets, Ramirez & Co., R. Seelaus & Co. LLC.
\nFiled: 12-28-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: MYTE
\nDescription: They are a leading luxury e-commerce platform for the global luxury fashion consumer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, Credit Suisse, UBS Investment Bank, Jefferies, Cowen
\nFiled: 12-28-20
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: MSGM
\nDescription: Motorsport Games is a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, including NASCAR, the iconic 24 Hours of Le Mans endurance race (\u201cLe Mans\u201d) and the associated FIA World Endurance Championship (the \u201cWEC\u201d), the British Touring Car Championship (the \u201cBTCC\u201d) and others.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Canaccord Genuity, The Benchmark Company
\nFiled: 12-18-20
\nListed Cash Raise: $40m<\/p>\n
\nSymbol: PLTK
\nDescription: They are one of the world\u2019s leading developers of mobile games creating fun, innovative experiences that entertain and engage our users.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Credit Suisse, Citigroup, Goldman Sachs, UBS Investment Bank, BofA Securities
\nCo-Manager(s): Baird, Cowen, Stifel, Wedbush Securities
\nFiled: 12-18-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: KUKE
\nDescription: They are a leading provider of classical music licensing, subscription and education services in China.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Deutsche Bank, Tiger Brokers, AMTD
\nFiled: 12-18-20
\nListed Cash Raise: $50m<\/p>\n
\nSymbol: CGEM
\nDescription: They are a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
\nShares: 8.33 million
\nPrice Range: $17.00-$19.00
\nMarket Cap: $643m-$719m
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, SVB Leerink, Evercore ISI
\nCo-Manager: HC Wainwright
\nTerms Added: 1-04-21<\/p>\n
\nSymbol: GRCL
\nDescription: They are a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical needs in the treatment of cancer.
\nShares: 8.825 million ADSs
\nPrice Range: $16.00-$18.00
\nMarket Cap: $1.0b-$1.14b
\nTrade Date: Friday, 1\/8
\nUnderwriter(s): Citigroup, Jefferies, Piper Sandler, Wells Fargo
\nTerms Added: 1-04-20<\/p>\n","protected":false},"excerpt":{"rendered":"